Clinical Trials Browser

Phase 1 × Completed × Solid Tumours × Clear all

NCT02360345 2024-09-26

ONX-0801

Phase 1 Completed

Other solid neoplasm

Solid Tumours

NCT06231277 2024-01-30

BH002-Ⅰ-101

Phase 1 Completed

Other solid neoplasm

Solid Tumours

NCT04179071 2020-07-07

A Study in Healthy Male Subjects to Understand How Savolitinib Behaves Inside the Body (Pharmacokinetics) When Administered Alone and in Combination With Famotidine

Phase 1 Completed

Other solid neoplasm

Solid Tumours

NCT02264418 2020-01-18

KIDES-203

Phase 1 Completed

Other solid neoplasm

Solid Tumours

NCT03333824 2019-03-25

Effects of AZD1775 on the PK Substrates for CYP3A, CYP2C19, CYP1A2 and on QT Interval in Patients With Advanced Cancer

Phase 1 Completed

Other solid neoplasm

Solid Tumours

NCT03315091 2018-04-30

Phase I Study to Assess the Effect of Food on AZD1775 Pharmacokinetics in Patients With Advanced Solid Tumours

Phase 1 Completed

Other solid neoplasm

Solid Tumours

NCT00732420 2017-11-13

Open-label Study of Topotecan and Pazopanib in Advanced Solid Tumors

Phase 1 Completed

Other solid neoplasm

Solid Tumours

NCT00136578 2017-09-25

Ispinesib In Combination With Carboplatin In Patients With Solid Tumors

Phase 1 Completed

Other solid neoplasm

Solid Tumours

NCT00742131 2017-07-31

A Dose Escalation Study of the Safety and Pharmacokinetics of GSK1363089 (Formerly XL880) Administered Orally to Subjects With Solid Tumors

Phase 1 Completed

Other solid neoplasm

Solid Tumours

NCT00743067 2017-07-26

A Dose Escalation Study of the Safety and Pharmacokinetics of GSK1363089 (Formerly XL880) Administered Orally Daily to Subjects With Solid Tumors

Phase 1 Completed

Other solid neoplasm

Solid Tumours

NCT00742261 2017-07-07

A Bioavailability Study of GSK1363089 in Subjects With Solid Tumors

Phase 1 Completed

Other solid neoplasm

Solid Tumours

NCT02215850 2016-05-17

Safety Study of SLC-0111 in Subjects With Advanced Solid Tumours

Phase 1 Completed

Other solid neoplasm

Solid Tumours

NCT02056392 2015-11-09

To Assess the Effects of Single Oral Dose of Selumetinib [AZD6244; ARRY-142886] [Hyd-Sulfate]), on QTc Interval in Healthy Male Volunteers

Phase 1 Completed

54 enrolled 31 charts

Other solid neoplasm

Solid Tumours

NCT01931761 2015-06-30

Study Evaluating Absorption, Distribution, Metabolism and Excretion (ADME) of Single Dose [14C] Selumetinib in Volunteers

Phase 1 Completed

Other solid neoplasm

Solid Tumours

NCT02093728 2015-06-30

To Assess the Effect of Itraconazole and Fluconazole on the Pharmacokinetics of Selumetinib in Healthy Male Volunteers

Phase 1 Completed

Other solid neoplasm

Solid Tumours

NCT01974349 2014-08-13

To Assess the Effect of Food on the Pharmacokinetics of Selumetinib (AZD6244; ARRY-142886) (Hyd-Sulfate) in Healthy Male Volunteers

Phase 1 Completed

Other solid neoplasm

Solid Tumours

NCT02046850 2014-04-29

To Assess the Effect of Rifampicin on the Pharmacokinetics of Selumetinib in Healthy Male Volunteers

Phase 1 Completed

Other solid neoplasm

Solid Tumours